Use of skin substitute dressings in the treatment of staphylococcal scalded skin syndrome in neonates and young infants

Neonatology. 2011;100(1):9-13. doi: 10.1159/000317997. Epub 2010 Dec 9.

Abstract

Background: Staphylococcal scalded skin syndrome (SSSS) is a rare toxin-mediated skin disease caused by Staphylococcus aureus and seen in infants and children younger than 5 years.

Objectives: The supportive role of skin substitutes in SSSS is stressed as a new and relatively unknown method.

Methods: Retrospective observational case-series study, in neonates and young infants diagnosed with SSSS.

Results: Seven infants with SSSS, treatment with antibiotics, skin substitutes, strict pain relief strategy and prognosis were described. One of them was severely affected and deceased.

Conclusion: This study describes 7 infants with SSSS and stresses the important role of skin substitutes as Omiderm® and Suprathel® as valuable adjuvant treatment modality.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Administration, Cutaneous
  • Age Factors
  • Anti-Bacterial Agents / administration & dosage
  • Biological Dressings* / statistics & numerical data
  • Combined Modality Therapy
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases / therapy*
  • Male
  • Retrospective Studies
  • Skin, Artificial / statistics & numerical data*
  • Staphylococcal Scalded Skin Syndrome / therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents